Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease
Work with genome editing techniques (zinc fingers and CRISPR) brings these tools closer to use in HD clinical trials
HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD
Electrons enable huntingtin protein, the cause of Huntington's disease, to be visualised at highest resolution ever
Harmful misfolded huntingtin can travel between brain cells via messenger particles called exosomes
A confusing story about a huntingtin lowering trial is published in the Telegraph, but cool new stuff is happening!
An existing drug could give a boost to HD brain cells – but it may need more testing before it’s back in the clinic
Major Announcement: First HD patients treated with gene silencing drugs
A better tool for HD trials! New research shows innovative way to measure mutant Huntingtin outside the brain